Anavex Life Sciences Corp. (AVXL)
Anavex Board Appoints Former SVP of Clinical Development Terrie Kellmeyer, PhD, as Interim Chief Executive Officer
Anavex Board Appoints Former SVP of Clinical Development Terrie Kellmeyer, PhD, as Interim Chief Executive Officer
📊 **NEUTRAL** • Medium confidence analysis (70%) • Weak clinical signals • Minimal impact anticipated **Sentiment:** Neutral (50%) **Content type:** Clinical